There have been no adverse events attributed for the procedure, which led to a 100 percent lower in unbound N-terminal tau fragments in CSF. There have been no outcomes on exploratory measures of condition severity.Even with these promising developments, there are troubles to address. Longitudinal studies are required to confirm whether STA concent